Top Markets
#1 Black Phoenix Black Phoenix +365.85%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.05%
#5 Akedo Akedo +34.14%
#6 BasedHype BasedHype +29.84%
#7 Acurast Acurast +27.03%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.11%
#9 Cryptopia Cryptopia +21.42%
#10 GoPlus Security GoPlus Security +20.47%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classifica tra le azioni #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Prezzo delle azioni
$0.0202
Ultima sincronizzazione: 2024-11-19
Capitalizzazione di mercato
$44.67K
Variazione (1 giorno)
-0.49%
Variazione (1 anno)
0.00%
Paese
IL
Scambia Notable Labs, Ltd. (NTBL)

Categoria

Healthcare
Rapporto P/B per Notable Labs, Ltd. (NTBL)
Rapporto P/B al August 2026 TTM: 0.04
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Notable Labs, Ltd., il rapporto P/B attuale (TTM) è 0.04. Alla fine del 2022, era pari a -0.25.
Storico del rapporto P/B per Notable Labs, Ltd. da 2015 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.04 -86.41%
2023 0.27 -208.34%
2022 -0.25 -99.73%
2021 -93.37 -186.36%
2020 108.12 83.51%
2019 58.92 179.46%
2018 21.08 -82.69%
2017 121.80 21.83%
2016 99.97 -6.40%
2015 106.81 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 16,960.76%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 17,197.82%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 9,801.91%
BE